查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829650

2025年全球避孕設備市場報告

Contraceptive Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，避孕設備市場規模強勁成長，從2024年的128億美元增加至2025年的135.5億美元，複合年成長率為5.9%。這段歷史時期的成長可歸因於人們對計劃生育和避孕重要性的認知不斷提高、政府舉措、全球人口成長、對女性健康和賦權的日益關注以及醫療設施可及性的改善。

預計未來幾年避孕設備市場規模將強勁成長，到2029年將達到172.5億美元，複合年成長率為6.2%。預測期內的成長可歸因於人們對性健康和性傳播疾病預防意識的提高、控制家庭規模的經濟效益、避孕器文化接受度的提高、育齡青年比例的提高以及社交媒體在傳播避孕意識方面的影響力。預測期內的主要趨勢包括避孕技術的創新、非政府組織和衛生組織的教育宣傳活動、藥物配方的進步、避孕產品的普及以及對新型避孕方法研發的投資。

避孕藥具是用來預防懷孕的醫療器材。避孕器具種類繁多，每種避孕機制和效果各不相同。這些裝置主要用於預防意外懷孕，在某些情況下也用於預防性性行為感染(STI)。

避孕器具的主要類型包括男性避孕藥、女性用避孕藥、女性用保險套、隔膜和海綿、避孕環、子宮內避孕器和皮下植入。男用避孕器具是男性用來預防懷孕的方法，例如保險套和輸精管結紮。這些避孕器具包括荷爾蒙避孕法和屏障避孕法。這些器具透過各種管道分銷，包括醫院藥房、零售藥房、診所、線上平台、公共管道和非政府組織 (NGO)。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供避孕設備市場統計數據，例如全球市場規模、區域佔有率、避孕設備市場佔有率競爭對手、詳細的避孕設備細分市場、市場趨勢和商業機會，以及您在避孕設備行業取得成功所需的數據。本避孕設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切全面觀點。

未來五年6.2%的預測成長率比我們先前對該市場的預測略有下降，下降了0.1%。下降的主要原因是美國與其他國家之間關稅的影響。美國可能會直接感受到關稅的影響，因為這些避孕器來自荷蘭和愛爾蘭等主要地區，這可能導致計劃生育選擇減少，生殖健康成本上升。此外，關稅的互惠效應以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，可能會對全球經濟和貿易產生更廣泛的負面影響。

性行為感染傳染病 (STD) 的日益普及預計將推動避孕器市場的成長。性感染疾病主要透過性接觸傳播，影響身體的各個部位，並可能導致各種症狀和健康問題。性傳染病流行率的上升與性活動活性化、保護措施不足、性教育不足以及難以獲得醫療保健和檢測等因素有關。避孕裝置，尤其是保險套，對於預防性傳染病至關重要，因為它們透過防止直接接觸傳染性體液和病變部位，形成一道屏障，降低感染風險。例如，根據英國衛生安全局 2024 年 7 月的報告，2023 年英格蘭新診斷的性傳染感染病例為 401,800 例，比前一年的 383,789 例增加了 4.7%。預計淋病診斷數量將從 2022 年的 79,268 例增加 7.5% 至 2023 年的 85,223 例，而傳染性梅毒診斷數量預計將從 2022 年的 8,693 例增加 9.4% 至 2023 年的 9,513 例。性傳染病盛行率的上升正在推動對避孕設備的需求。

避孕設備市場中的公司正專注於開發創新產品，例如避孕避孕環。產品每月放置一次，即可提供便利、低維護的避孕效果。避孕避孕環是一種佩戴在陰道內的軟性荷爾蒙釋放裝置。它透過持續釋放抑制排卵和增稠子宮頸黏液的激素來防止懷孕。例如，2023年10月，美國製藥公司Xiromed LLC宣布推出Eniroring。這款由Xiromed開發的避孕避孕環結合了依托孕烯和炔雌醇，旨在長期使用，在佩戴三週後停用一周。

2023年12月，美國生命科學公司Aditxt以1億美元收購了Evofem Biosciences。此次收購涵蓋了Evofem已獲FDA核准的無激素避孕凝膠Phexxi®（乳酸、檸檬酸、酒石酸鉀）。 Aditxt旨在透過此次收購，加強其在自體免疫、健康指標、延長壽命的移植技術、人口健康和女性健康領域的創新。此次收購增強了Aditxt的合作生態系統，並最大限度地發揮了其子公司的潛力。 Evofem Biosciences是美國避孕設備製造商。

避孕設備市場包括子宮頸帽、荷爾蒙注射、緊急避孕設備和避孕產品的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球避孕藥具：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球避孕設備市場：成長率分析
  • 全球避孕設備市場表現：規模與成長，2019-2024
  • 全球避孕設備市場預測：2024-2029年、2034年規模與成長
  • 全球避孕設備：總目標市場（TAM）

第6章 市場細分

  • 全球避孕設備市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 男性避孕器
  • 女性用避孕器
  • 女性用保險套、隔膜、海綿
  • 避孕環
  • 子宮內避孕器
  • 皮下植入
  • 其他產品類型
  • 全球避孕設備市場技術、性能及預測（2019-2024、2024-2029、2034）
  • 荷爾蒙避孕藥
  • 工具避孕
  • 全球避孕設備市場依通路分類：2019-2024 年、2024-2029 年、2034 年實際資料及預測
  • 醫院藥房
  • 零售藥局
  • 診所
  • 線上管道
  • 公共管道和非政府組織（NGO）
  • 其他分銷管道
  • 全球避孕設備市場：男性避孕器的細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 男用保險套
  • 輸精管切除器械
  • 男性避孕注射劑
  • 男性避孕藥
  • 全球避孕設備市場：女性用避孕器細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 女性用保險套
  • 隔膜和海綿
  • 避孕環
  • 子宮內避孕器（IUD）
  • 皮下植入
  • 緊急避孕器
  • 全球避孕設備市場：女性用保險套細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 乳膠女性用保險套
  • 非乳膠女性用保險套
  • 全球避孕設備市場：依隔膜及海綿細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 矽振膜
  • 乳膠隔膜
  • 避孕海綿
  • 全球避孕設備市場：避孕環細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • NuvaRing（和其他荷爾蒙避孕環）
  • 非荷爾蒙避孕環
  • 全球避孕設備市場：子宮內避孕器（IUD）細分、類型、性能及預測（2019-2024、2024-2029、2034）
  • 銅子宮內避孕器
  • 荷爾蒙子宮內避孕器
  • 非荷爾蒙子宮內避孕器
  • 全球避孕設備市場：皮下植入物細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 荷爾蒙植入
  • 非荷爾蒙植入
  • 全球避孕設備市場：按其他產品類型細分（按類型）、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 避孕貼片
  • 避孕注射
  • 避孕藥
  • 避孕凝膠和乳膏

第7章 區域和國家分析

  • 全球避孕設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球避孕設備市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 避孕設備市場：競爭格局
  • 避孕設備市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Mylan NV
  • Organon Group
  • Hologic Inc.
  • CooperSurgical Inc.
  • Cipla Inc.
  • Mankind Pharma Ltd.
  • TTK HealthCare Ltd.
  • Zondervan
  • Merck Sharp & Dohme Corp.
  • Evofem Biosciences Inc.
  • Veru Inc.
  • Medisafe Inc.
  • Agile Therapeutics Inc.
  • Janssen Global Services LLC
  • HLL Lifecare Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年避孕設備市場：提供新機會的國家
  • 2029年避孕設備市場：細分市場將帶來新機會
  • 2029年避孕設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29886u

Contraceptive devices are medical tools designed to prevent pregnancy. They come in various forms, each with distinct mechanisms and levels of effectiveness. These devices are primarily used to avoid unintended pregnancies and, in some cases, offer protection against sexually transmitted infections (STIs).

The main types of contraceptive devices include male contraceptive devices, female contraceptive devices, female condoms, diaphragms and sponges, vaginal rings, intrauterine devices, sub-dermal implants, and others. Male contraceptive devices, such as condoms and vasectomy procedures, are methods used by men to prevent pregnancy. They include both hormonal and barrier methods. These devices are distributed through various channels, including hospital pharmacies, retail pharmacies, clinics, online platforms, public channels, non-governmental organizations (NGOs), and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The contraceptive devices market research report is one of a series of new reports from The Business Research Company that provides contraceptive devices market statistics, including contraceptive devices industry global market size, regional shares, competitors with a contraceptive devices market share, detailed contraceptive devices market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptive devices industry. This contraceptive devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The contraceptive devices market size has grown strongly in recent years. It will grow from $12.8 billion in 2024 to $13.55 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to growing awareness about the importance of family planning and contraceptive methods, government initiatives, increasing global population, greater focus on women's health and empowerment, improving access to healthcare facilities.

The contraceptive devices market size is expected to see strong growth in the next few years. It will grow to $17.25 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing awareness of sexual health and STD prevention, economic benefits of controlling family size, growing cultural acceptance of contraceptive use, high proportion of young population in reproductive age, influence of social media on spreading awareness. Major trends in the forecast period include innovations in contraceptive technologies, educational campaigns by NGOs and health organizations advancements in pharmaceutical formulations, availability of a wide range of contraceptive products, investment in research and development for new contraceptive methods.

The forecast of 6.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on hormone-eluting polymers and intrauterine device placement systems, sourced from key regions such as the Netherlands and Ireland, which could lead to reduced family planning options and increased reproductive healthcare costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of sexually transmitted diseases (STDs) is expected to drive growth in the contraceptive device market. STDs are infections primarily spread through sexual contact, affecting various body parts and potentially causing a range of symptoms and health issues. Rising STD rates are linked to factors such as higher sexual activity, inadequate protection, insufficient sexual health education, and difficulties accessing healthcare and testing. Contraceptive devices, particularly condoms, are essential for preventing STDs as they create a barrier that reduces the risk of transmission by preventing direct contact with infectious fluids and lesions. For example, a report by the UK Health Security Agency in July 2024 noted 401,800 new STI diagnoses in England in 2023, a 4.7% increase from the previous year's 383,789 cases. Gonorrhoea diagnoses rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023, while infectious syphilis diagnoses increased by 9.4%, from 8,693 in 2022 to 9,513 in 2023. This growing prevalence of STDs is driving demand for contraceptive devices.

Companies in the contraceptive device market are focusing on developing innovative products, such as contraceptive vaginal rings, to offer convenient, low-maintenance birth control with a once-a-month insertion. A contraceptive vaginal ring is a flexible, hormone-releasing device placed in the vagina, which prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, introduced the EnilloRing. This contraceptive vaginal ring, developed by Xiromed, combines etonogestrel and ethinyl estradiol and is designed for long-term use, remaining in place for three weeks, followed by a one-week ring-free interval.

In December 2023, Aditxt, a US-based life sciences company, acquired Evofem Biosciences for $100 million. This acquisition includes Evofem's FDA-approved hormone-free contraceptive gel, Phexxi(R) (lactic acid, citric acid, and potassium bitartrate). Aditxt aims to use this acquisition to bolster its focus on innovations in autoimmunity, health metrics, life-extending transplant technologies, population health, and women's health. This acquisition enhances Aditxt's collaborative ecosystem and maximizes the potential of its subsidiaries. Evofem Biosciences is a US-based manufacturer of contraceptive devices.

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Boehringer Ingelheim International GmbH., Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Zondervan, Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Medisafe Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

North America was the largest region in the contraceptive devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the contraceptive devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The contraceptive devices market consists of sales of cervical caps, hormonal injections, emergency contraceptive devices and sterilization products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contraceptive Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contraceptive devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contraceptive devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contraceptive devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Male Contraceptive Devices; Female Contraceptive Devices; Female Condoms, Diaphragms And Sponges; Vaginal Rings; Intrauterine Devices; Sub-Dermal Implants; Others Product Types
  • 2) By Technology: Hormonal Contraceptives; Barrier Contraceptives
  • 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channels; Public Channel And Non-Governmental Organization (NGO); Other Distribution Channels
  • Subsegments:
  • 1) By Male Contraceptive Devices: Male Condoms; Vasectomy Devices; Male Contraceptive Injections; Male Contraceptive Pills
  • 2) By Female Contraceptive Devices: Female Condoms; Diaphragms And Sponges; Vaginal Rings; Intrauterine Devices (IUDs); Sub-Dermal Implants; Emergency Contraceptive Devices
  • 3) By Female Condoms: Internal Latex Female Condoms; Non-Latex Female Condoms
  • 4) By Diaphragms And Sponges: Silicone Diaphragms; Latex Diaphragms; Contraceptive Sponges
  • 5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings); Non-Hormonal Vaginal Rings
  • 6) By Intrauterine Devices (IUDs): Copper IUDs; Hormonal IUDs; Non-Hormonal IUDs
  • 7) By Sub-Dermal Implants: Hormonal Implants; Non-Hormonal Implants
  • 8) By Other Product Types: Contraceptive Patches; Contraceptive Injections; Contraceptive Pills; Contraceptive Gel And Creams
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Boehringer Ingelheim International GmbH.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Organon Group; Hologic Inc.; CooperSurgical Inc.; Cipla Inc.; Mankind Pharma Ltd.; TTK HealthCare Ltd.; Zondervan; Merck Sharp & Dohme Corp.; Evofem Biosciences Inc.; Veru Inc.; Medisafe Inc.; Agile Therapeutics Inc.; Janssen Global Services LLC; HLL Lifecare Ltd.; Mayer Laboratories Inc.; V-Care Pharma Pvt. Ltd.; Vardhaman Lifecare Pvt. Ltd.; Actavis Pharma LLC; Pregna International Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Contraceptive Devices Market Characteristics

3. Contraceptive Devices Market Trends And Strategies

4. Contraceptive Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Contraceptive Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Contraceptive Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Contraceptive Devices Market Growth Rate Analysis
  • 5.4. Global Contraceptive Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Contraceptive Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Contraceptive Devices Total Addressable Market (TAM)

6. Contraceptive Devices Market Segmentation

  • 6.1. Global Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Male Contraceptive Devices
  • Female Contraceptive Devices
  • Female Condoms, Diaphragms And Sponges
  • Vaginal Rings
  • Intrauterine Devices
  • Sub-Dermal Implants
  • Others Product Types
  • 6.2. Global Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hormonal Contraceptives
  • Barrier Contraceptives
  • 6.3. Global Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channels
  • Public Channel And Non-Governmental Organization (NGO)
  • Other Distribution Channels
  • 6.4. Global Contraceptive Devices Market, Sub-Segmentation Of Male Contraceptive Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Male Condoms
  • Vasectomy Devices
  • Male Contraceptive Injections
  • Male Contraceptive Pills
  • 6.5. Global Contraceptive Devices Market, Sub-Segmentation Of Female Contraceptive Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Female Condoms
  • Diaphragms And Sponges
  • Vaginal Rings
  • Intrauterine Devices (IUDs)
  • Sub-Dermal Implants
  • Emergency Contraceptive Devices
  • 6.6. Global Contraceptive Devices Market, Sub-Segmentation Of Female Condoms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Internal Latex Female Condoms
  • Non-Latex Female Condoms
  • 6.7. Global Contraceptive Devices Market, Sub-Segmentation Of Diaphragms And Sponges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Silicone Diaphragms
  • Latex Diaphragms
  • Contraceptive Sponges
  • 6.8. Global Contraceptive Devices Market, Sub-Segmentation Of Vaginal Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NuvaRing (And Other Hormonal Vaginal Rings)
  • Non-Hormonal Vaginal Rings
  • 6.9. Global Contraceptive Devices Market, Sub-Segmentation Of Intrauterine Devices (IUDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Copper IUDs
  • Hormonal IUDs
  • Non-Hormonal IUDs
  • 6.10. Global Contraceptive Devices Market, Sub-Segmentation Of Sub-Dermal Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hormonal Implants
  • Non-Hormonal Implants
  • 6.11. Global Contraceptive Devices Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Contraceptive Patches
  • Contraceptive Injections
  • Contraceptive Pills
  • Contraceptive Gel And Creams

7. Contraceptive Devices Market Regional And Country Analysis

  • 7.1. Global Contraceptive Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Contraceptive Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Contraceptive Devices Market

  • 8.1. Asia-Pacific Contraceptive Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Contraceptive Devices Market

  • 9.1. China Contraceptive Devices Market Overview
  • 9.2. China Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Contraceptive Devices Market

  • 10.1. India Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Contraceptive Devices Market

  • 11.1. Japan Contraceptive Devices Market Overview
  • 11.2. Japan Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Contraceptive Devices Market

  • 12.1. Australia Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Contraceptive Devices Market

  • 13.1. Indonesia Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Contraceptive Devices Market

  • 14.1. South Korea Contraceptive Devices Market Overview
  • 14.2. South Korea Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Contraceptive Devices Market

  • 15.1. Western Europe Contraceptive Devices Market Overview
  • 15.2. Western Europe Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Contraceptive Devices Market

  • 16.1. UK Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Contraceptive Devices Market

  • 17.1. Germany Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Contraceptive Devices Market

  • 18.1. France Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Contraceptive Devices Market

  • 19.1. Italy Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Contraceptive Devices Market

  • 20.1. Spain Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Contraceptive Devices Market

  • 21.1. Eastern Europe Contraceptive Devices Market Overview
  • 21.2. Eastern Europe Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Contraceptive Devices Market

  • 22.1. Russia Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Contraceptive Devices Market

  • 23.1. North America Contraceptive Devices Market Overview
  • 23.2. North America Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Contraceptive Devices Market

  • 24.1. USA Contraceptive Devices Market Overview
  • 24.2. USA Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Contraceptive Devices Market

  • 25.1. Canada Contraceptive Devices Market Overview
  • 25.2. Canada Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Contraceptive Devices Market

  • 26.1. South America Contraceptive Devices Market Overview
  • 26.2. South America Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Contraceptive Devices Market

  • 27.1. Brazil Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Contraceptive Devices Market

  • 28.1. Middle East Contraceptive Devices Market Overview
  • 28.2. Middle East Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Contraceptive Devices Market

  • 29.1. Africa Contraceptive Devices Market Overview
  • 29.2. Africa Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Contraceptive Devices Market Competitive Landscape And Company Profiles

  • 30.1. Contraceptive Devices Market Competitive Landscape
  • 30.2. Contraceptive Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Contraceptive Devices Market Other Major And Innovative Companies

  • 31.1. Mylan N.V.
  • 31.2. Organon Group
  • 31.3. Hologic Inc.
  • 31.4. CooperSurgical Inc.
  • 31.5. Cipla Inc.
  • 31.6. Mankind Pharma Ltd.
  • 31.7. TTK HealthCare Ltd.
  • 31.8. Zondervan
  • 31.9. Merck Sharp & Dohme Corp.
  • 31.10. Evofem Biosciences Inc.
  • 31.11. Veru Inc.
  • 31.12. Medisafe Inc.
  • 31.13. Agile Therapeutics Inc.
  • 31.14. Janssen Global Services LLC
  • 31.15. HLL Lifecare Ltd.

32. Global Contraceptive Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contraceptive Devices Market

34. Recent Developments In The Contraceptive Devices Market

35. Contraceptive Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Contraceptive Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Contraceptive Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Contraceptive Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer